chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Just as the nurse started injecting the vaccine I felt a strong taste of metal in my mouth (similar to the times I have had CAT scans done).  In  a couple of minutes I felt very light headed.   While scheduling my second dose, I started feeling  strong pressure inside my head.  I didn't not feel any pain, just a lot of pressure.     When measuring my  blood pressure (usually, in my case,  it is 120 X 80)  I was told my high number was at 178 x 80.   After resting for some 20 minutes, I was fine again and drove home.    I felt a bit strange  for a couple of hours.
Rash on chest, arms, legs with welts. Treated with oral and topical antihistamine, topical cortisone cream. 1st noticed 11/06/09 still occurring but not as severe.
24h after vaccination:  Redness, Tenderness, Induration (~3cm)  on L thigh, at the site of vaccination.  Redness, Tenderness, Induration  (~2cm) on R thigh, at the site of vaccination.  High fever (40.5C)   Child was treated with Ceftriaxone and Clindamycin
Evening of second shot, developed fever of 101/I had a low grade fever; body aches/body aches during the entire time.; overall feeling ill; dry cough; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was en6202) via an unspecified route of administration, administered in left arm on 06Mar2021 at 15:45 (at the age of 56-years-old) at a single dose for COVID-19 immunization. Medical history included glaucoma and hypertension. The patient's concomitant medications were not reported.  Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and not received any other medications within 2 weeks of vaccination. Patient had no allergies to medications, food or other products; Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was en601) administered on left arm on 13Feb2021 at 15:45, single dose for COVID-19 immunization. The patient reported that on the evening of second shot, on 06Mar2021, he developed fever of 101, body aches, and overall feeling ill. This went on for two weeks. He had a low grade fever and body aches during the entire time. There were days that he spent in bed. The patient also mentioned that he developed a dry cough. No treatment was received for the events. The outcome of the events was recovered with lasting effects (recovered with sequel).
pt reported sxs of throat tightening, chest tightening 10 minutes post vaccine. She became faint, diaphoretic, BP increased then dropped, HR increased, mild wheezing developed. Epi 0.3 mg was administered and 50 mg Benadryl IM. PT was transported to ER by ambulance.
Both times I received  the COVID-19 vaccincations I instantly had a migranie and a fever when I got howm.  The first time my migraine lasted 4 days and I was out of work which has almost cost me my job.  The second times I had a migraine and a fever of over 104 last evening. I was able to break the fever in the middle of the night but it lasted a long time.
Shot administered at 10:00 am, hives noticed at 6:00 pm, took 2 BENADRYL capsules orally Wednesday evening, saw CNP at Clinic on Thurs at 11:30 am, was prescribed course of prednisone. Took prednisone and BENADRYL orally, used neosporin eczema lotion on affected areas (forearms, upper arms, legs, trunk, chest). Hives lasted 6 days.
-Mild tenderness in arm after injection -Chills, fever of around 102 lasting for approximately 12 hours -Body aches and fatigue both day of and day following vaccination
My arm itched for about 3 days after I received the Meningitis ACWY vaccine. I also had stiffness in varying parts of my body for about a week after.
patient was prescribed Bexsaro but was inadvertently given Menactra, no AE; second dose of Menactra given too soon after first dose of Menactra, no AE; Initial information was received on 07-Oct-2020 regarding an unsolicited valid non-serious case from the nurse.  This case involve a 17 years old female patient who was vaccinated with the first dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] on 25-Feb-2016 and second dose on 13-Aug-2018 (batch number and other dosing details were not reported), also received the 0.5 ml third dose of the same vaccine on 01-Oct-2020 (lot ABXA60BA and expiration date 30-Sep-2021) via an intramuscular route in the left deltoid instead of BEXSERO vaccine (not produced by Sanofi Pasteur) for prophylactic vaccination.  The patient's medical history, past medical treatments, vaccinations and family history were not provided.  This was an actual medication error case due to wrong vaccine administered (wrong product administered) and drug dose administration interval too short (inappropriate schedule of product administration), latency was same day.   Nurse stated that the second dose was given too soon hence that dose was not valid.  Also, the physician wants to know if it was ok for the patient to have the third dose.  At the time of reporting, patient had no adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number for this case.
Red, mildly swollen area, egg-sized and shaped, quite itchy, quite warm, on left arm at vaccination site.
While in our observation area, 3-5 minutes after vaccine given the patient passed out and voided bladder, gave patient water to drink, took two blood pressure measurements 84/49 with HR 44 at 11:41am and then 108/61 with HR 59 at 11:45.  He laid down in our counseling room for about 10 minutes under his mother's supervision and walked out on his own.
Sedation, Myalgia, Arthralgia, Fever, Diarrhea,  NauseaVomiting, chills, pain and swelling at the injection site. Narrative:   Other Relevant History:
Body aches; Abdominal pain (right); Fatigue; Chills; Nausea; Headache; Fever; Pain at injection site left; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Pain at injection site left) and CHILLS (Chills) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025JZo2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site left). On 20-Jan-2021, the patient experienced PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 21-Jan-2021, CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. At the time of the report, PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain (right)), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown and VACCINATION SITE PAIN (Pain at injection site left) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Urine analysis: abnormal (abnormal) Blood in urine.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided Treatment information provided as "antibiotic prescribed o/s BID started 21JAN2021"; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Within 12 hours of immuniation Child called to Mom and was found in a crawling position able to talk but unable to move.  His mother picked him up and he began having non-rhythmic myoclonic jerks of the arms and legs.  This continued for 40 minutes and resolved prior to arriving in the ER.  Dad held him for a while when this was occuring and he became glassy eyed but still communicated.  He also clenched his fists and ground his teeth.  He was cold to the touch when the episode began, at the Emergency Department he had a fever of 101. He had several myoclonic arm jerks the next 2 days, seemed uncordinated and less active on day 1 after immunization.
Information has been received from a RN concerning a 34 year old female with no medical history who on 11/4/05 was vaccinated IM in the left arm with a first dose of Pneumococcal 23v polysaccharide vaccine (lot 650541/1004P). There was no illness at the time of vaccination. On 11/4/05 the pts left arm became red, swollen, hot to touch and tender. On 11/5/05 the pt developed a fever to 103. On 11/6/05 the pt developed shortness of breath and a dry, hacky cough. She denied nasal congestion or chest pain. No medical attention was sought. On 11/14/05 the pt recovered. No further information is expected.
Patient lost consciousness after injection. Revived after use of ammonia inhalant-soon. Denies injury or any problem.
Left deltoid red, swollen, hard hot to touch, itching, no fever child eating and sleeping well.
This study case was received from the investigator on 19 August 2011. A 30-year-old male subject received on 03 June 2011 received the following vaccinations: an injection of ACAM2000 (lot number not reported), anthrax vaccine (manufacturer and lot number not reported), Tdap (manufacturer and lot number not reported) and TYPHOID Vi polysaccharide(lot not reported). Medical history was not available. On 20 June 2011, the subject had an abnormal electrocardiogram (ECG) and a normal echocardiogram. The subject's Troponin I was not available. On 20 June 2011, the subject was diagnosed acute pericarditis, unspecified. The outcome was not reported. Additional information will be requested from the investigator. There is no reporter causality assessment as this is a safety surveillance study. Documents held by sender: None.
rashes on the right hand; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rashes on the right hand) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced RASH (rashes on the right hand). At the time of the report, RASH (rashes on the right hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. concomitant information was not provided.
1 hour after shot given pt experienced redness and swelling at injection site. Side effects peaked at day 8. Pt reports no pain at any point. There is still internal swelling that feels like a lump. Slight redness still visible.
4/1/03, 8:30 am, experiencing compressed feeling to chest and mid back area, shortness of breath, feeling guarded, "spacey," feeling irritable.  Then experienced also sporadic pain to rt arm just above elbow that occurred about 20 times in course of a few hours.  Went to ER at 7 pm.
Three weeks after the vaccine I developed a rash on my back, stomach, arms and thighs
Developed hives within 2 hrs/took Benadryl that night; swelling that traveled up the arm and neck in the morning with shortness of breath/used rescue inhaler at 0400 and then again at 0800; and then anaphylaxis by 0900. Treated in ED with EpiPen then IV Solumedrol, Benadryl and Famotidine. Recovered and started on prednisone taper pack starting at 6 tabs for 3 days etc. Suggested to make follow up Dr appt for one week following incident/set for Feb 8
Patient reports she received at  1330 than was working and had a sudden onset of chest pain and became diaphoretic and skin appeared red/blotchy
Two hours after vaccination, patient felt nauseaus. Symptoms worsened by that afternoon to include, headache, light-headedness, stomach ache, aching joints (knuckles), aching teeth, loss of appetite, fever, shakes, and diarrhea. Resolved with OTC medication (Immodium and Tylenol PRN) after 5 days.
No adverse symptoms reported; inadvertently administered an expired dose of VAQTA; This spontaneous report was received from a medical assistant and refers to a 18-month-old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not provided.  On 29-JUL-2020, the patient was inadvertently vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA) lot # S007768 confirmed to be valid, expiration date reported as 24-JUL-2020 for prophylaxis (exact dose, route of administration and anatomical location were not provided). No adverse symptoms were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; manufactureraddress:; manufacturercity:; manufacturerstate:; manufacturercountry:; devicelotnumber: S007768; expirationdate: 24-JUL-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Nausea, vomiting , dizziness when lying down and on the sides, dizziness when standing up,  dizziness when bending over. Muscles aches and migraines. Feeling lightheaded continuously and unable to focus.  Feeling tired and fatigued.  This last most of the night. Nausea, vomiting , muscles aches and migraines stopped the next day but other described symptoms remained until Tuesday 04/27/2021. As of Wednesday 04/28/2021, lightheadedness and fatigue are still felt.
Patient said on injection the arm started the hurt. Pain did not resolve. Pain worsened. Patient went to ER around 3 weeks later due to increasing pain
ED to Hosp-Admission Discharged 8/29/2021 (20 hours)  Hospital Acute respiratory distress Presenting Problem/History of Present Illness/Reason for Admission Acute respiratory distress [R06.03] Respiratory distress [R06.03] Acute cystitis without hematuria [N30.00] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID-19 [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82]     Hospital Course   Patient admitted to monitored floor. She was started on non-invasive ventilation, found to have renal failure, and signs of severe sepsis. Upon admission goals of care meeting was held and family opted to withdraw active treatment and transition the patient comfort care.    Active Issues Requiring Follow-up Not applicable patient expired
Pt had one set of immunizations on 1/13/00. At the next visit on 5/11/00, mom reported "pupils got tiny, eyes glazed, hands got super hot, lost weight and left arm went limp". Now on 4/25/02, still complains of left leg smaller than the right; not apparent to me on exam. Not previously reported because not clear adverse event. Mother has never been immunized; very against immunization benefit.
tingling in fingers and toes, low vitamin B12 requiring injections, then diagnosed w lupus nephritis by biopsy
This is spontaneous report from a contactable other healthcare professional based on information received from agency. A patient of unspecified age, ethnicity and gender received PREVNAR 13 via an unspecified route of administration on an unspecified date at a single dose in the arm for immunization. The patient has no medical history. There were no concomitant medications. On an unspecified date, the reporter stated that after the patient received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein), patient experienced had a bad reaction on right arm. The outcome of the event was unknown.
headache; fatigue; dry mouth; minor nausea; minor body aches; This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient) reported for herself. A 23-year-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ER8729, Expiry date: unknown) via an unspecified route of administration, administered in left arm on 13Apr2021 10:30 am (age at vaccination was 23-year-old) at a single dose for COVID-19 immunization. Medical history included ADHD and anxiety. Allergies to medications, food, or other products included shellfish, seasonal pollen allergies and cockroaches. Concomitant medications patient received within 2 weeks of vaccination included lisdexamfetamine mesilate (VYVANSE), ethinylestradiol, ferrous fumarate, norethisterone acetate (HAILEY 24 FE), echinacea (ECHINACEA) and cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]). On 13Apr2021, the patient experienced regular expected side effects of headache and fatigue, but also experienced dry mouth starting about 2 hours after the shot for the duration of the day. Along with minor nausea infrequently and minor body aches. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of all the events was recovering.  No follow-up attempts are needed. No further information is expected.
Two days after receiving the vaccination, patient reported arm pain and numbness in left arm. Patient saw multiple doctors on 10/3, 10/6, 10/7, and 10/19. She displayed a bruise on her left arm, continued numbness, and swollen lymph nodes for which she was given antibiotics (not disclosed). One of her doctors gave Gabapentin for the nerve pain. To compensate for not using her left arm during subsequent physical activities, patient over-worked her right arm, lower back, and upper back. No further details of dates, diagnoses, and physical evaluations were given by patient.
Got her 1st dose and then fell; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 15Apr2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer (patient husband) reporting for her wife that a female patient of an unspecified age received Covid-19 vaccine (unspecified trade name or manufacture), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported.  The patient got her 1st dose and then fell on an unspecified date with outcome of unknown. Her HCP put her on Naproxen. He wants to know if that will interfere with the Covid vaccine.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt sent to waiting room to wait customary 10 minutes after vaccination. Approx. 2 minutes later a support staff came looking for PHN stating that pt was sick. PHN went to waiting room where pt was found to be stiff with eyes unfocused. After several seconds he came out of it and said he was fine. At that time he was noted to be pale so 2L O2 was admin via non-rebreather mask. Pulse was noted to be weak, around 50bpm and unable to obtain BP. After several minutes pt was brought back into the exam room and layed on table. BP at that time was 100/62 with pulse in 50s. Back was noted to be sweaty and color was still pale. 911 was called. Rescue squad arrived approx 9:40. 9:45 BP was 110/70, pulse 60, PO2 99%, PERLA. Pt taken to ER for eval. Mom reported pt was feeling dizzy for 10-15 seconds then went into "seizure" for 10-15 seconds. She noted him to be pale in color and warm.
It was reported that an adult male pt received an Imovax ID vaccination. Reportedly sometime after the vaccination the pt complained of swelling, induration and redness (20mm) of the entire deltoid, which was also hot to touch. A blister measuring 5mm broke with serosanguineous drainage. Further information requested.
I received my first shot on July 27, 2021. After receiving my first shot I stood up and felt warmth throughout my left side, from my arm to my foot. I left within two  minutes it was gone.
This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a 12-year-old female patient who received MENVEO. On 20th April 2012, the patient received the 1st dose of MENVEO (intramuscular). On 20th April 2012, less than a day after receiving MENVEO, the patient experienced swelling arm (serious criteria hospitalization), pruritus (serious criteria hospitalization) and erythema (serious criteria hospitalization). On an unknown date, the outcome of the swelling arm, pruritus and erythema were unknown. It was unknown if the reporter considered the swelling arm, pruritus and erythema to be related to MENVEO. Additional details were provided as follows: The patient received MENVEO in an unknown arm. On the next day after vaccination, the patient's whole arm was affected. The patient was taken to the emergency room (ER) and was initially diagnosed with cellulitis. The patient was admitted to the hospital and cellulitis was ruled out. It was decided to be a reaction to the MENVEO vaccine. The patient had not received any further MENVEO injections, but college was requiring her to be vaccinated before attending, so they are trying to determine what she reacted to. The patient was tested for an allergy to formaldehyde, but that was found negative. The batch number information was unknown. The reporter denied permission to contact the physician.
On Sunday 3/7/21 9pm left eye started getting red & edematous. Monday morning 3/8 /21 Left eye was more swollen, red,  crusting , yellow drainage. Sclera--white, no change in vision. Went to eye doctor @2pm Monday. Stated I have multiple infected stye's on left  lower eye lid. Prescribed Keflex 500mg bid & eye drops with Tobramycin and Dexamethasone tid.  Symptoms lessened in 36 hours.  However Tues. 3_/9 I started developing a fever blister on my upper lip.
On April 2, 2021 a rash appeared at the injection site and it felt itchy.
PATIENT RECEIVED MODERNA VACCINE ON 9/22/2021 AND VACCINE EXP ON 09/17/2021